XML 52 R60.htm IDEA: XBRL DOCUMENT v3.20.1
Equity (Details Textual) - USD ($)
 1 Months Ended 12 Months Ended
May 03, 2019
Mar. 12, 2019
Feb. 08, 2019
Feb. 08, 2019
Mar. 21, 2016
Feb. 08, 2016
Aug. 31, 2019
Feb. 28, 2017
Oct. 02, 2016
Aug. 26, 2016
May 06, 2016
Mar. 31, 2016
Feb. 17, 2016
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Mar. 28, 2018
Aug. 31, 2017
May 26, 2017
Equity (Textual)                                      
Common stock, par value         $ 0.001                 $ 0.001 $ 0.001        
Description of forward split The Company filed a certificate of amendment to the Company's articles of incorporation (the "Amendment") to effect the Reverse Split with the Secretary of State of Nevada. The Financial Industry Regulatory Authority ("FINRA") informed the Company that the Reverse Split was effective on May 8, 2019. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split. i) effect a stock reverse split at the ratio of 1-for-18 (the "Reverse Split") of both the authorized common stock of the Company (the "Common Stock") and the issued and outstanding Common Stock and ii) to amend the articles of incorporation of the Company to reflect the Reverse Split. The Board approved and authorized the Reverse Split without obtaining approval of the Company's shareholders pursuant to Section 78.207 of Nevada Revised Statutes.     1 to 3.141                            
Percentage of common shares issued and outstanding                                   73.00%  
Issuance of common shares                             $ 80,000        
Due to related parties                           $ 425,689 $ 7,745,096 $ 4,229,320      
Common stock, shares issued                           19,478,168 11,884,804 213,746,647      
Financial amendment, description                           The Company filed a Certificate of Amendment with the Secretary of State of Nevada, which was effective May 8, 2019 upon its receipt of the written notice from Financial Industry Regulatory Authority ("FINRA"). Pursuant to the Certificate of Amendment, the Company effectuated a 1-for-18 reverse stock split of its issued and outstanding shares of common stock, $0.001 par value, whereby 318,485,252 outstanding shares of the Company's common stock were exchanged for 17,693,625 shares of the Company's Common Stock. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split.          
Agreement, description               The Company remitted this amount to BioLite with $650,000 in cash and $5,850,000 in the form of newly issued shares of the Company's Common Stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares. Upon the consummation of the restructuring transaction between the Company and BioLite on February 8, 2019, the Company's Common Stock held by BioLite Taiwan was accounted for treasury stocks in the statement of equity (deficit).   The Company issued 1,468,750 shares ("Shares") of the Company's Common Stock, par value $0.001 (the "Offering") to BioLite Taiwan pursuant to a certain Stock Purchase Agreement dated August 26, 2016 (the "SPA"). The Shares are exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Regulation S of the Securities Act promulgated thereunder. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from the Offering are approximately $2,350,000. Pursuant to the BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of the Company with equivalent value according to the milestone achieved. The agreement requires that 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which was submitted in March 2016. The Company and BioLite Taiwan agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone Payment Agreement, whereby the Company has agreed to issue shares of Common Stock of the Company, at the price of $1.60 per share, for an aggregate number of 562,500 shares, as part of the Company's first installation of payment pursuant to the Milestone Payment. The shares issuance was completed in June 2016.                
Due to related parties consideration             $ 4,872,340                        
Common stock price per share             $ 7.00                        
Kimho Consultants Co., Ltd [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Common stock, shares issued                                 75,000    
Common stock, shares issued total                                 120,000    
2016 Equity Incentive Plan [Member]                                      
Equity (Textual)                                      
Common stock issued pre-stock split                         50,000            
Common stock issued post-stock split                         157,050            
Share Exchange Agreement [Member]                                      
Equity (Textual)                                      
Description of forward split           ABVC issued an aggregate of 104,558,777 shares (prior to the reverse stock split in 2019) to the shareholders of both BioLite and BioKey under a registration statement on Form S-4 (file number 333-226285), which became effective by operation of law on or about February 5, 2019.                          
Common stock issued pre-stock split           52,336,000                          
Common stock issued post-stock split           164,387,376                          
Share Exchange Agreement One [Member]                                      
Equity (Textual)                                      
Common stock issued pre-stock split           52,936,583                          
Common stock issued post-stock split           166,273,921                          
Share Exchange Agreement Two [Member]                                      
Equity (Textual)                                      
Common stock issued pre-stock split           51,945,225                          
Common stock issued post-stock split           163,159,952                          
Percentage of common shares issued and outstanding           79.70%                          
Percentage of issued share capital           100.00%                          
Share Exchange Agreement Three [Member]                                      
Equity (Textual)                                      
Common stock issued pre-stock split           52,936,583                          
Common stock issued post-stock split           166,273,921                          
Exchange ratio           0.2536-for-1                          
Share Exchange Agreement Four [Member]                                      
Equity (Textual)                                      
Common stock issued pre-stock split           65,431,144                          
Common stock issued post-stock split           205,519,223                          
Collaborative Arrangement [Member]                                      
Equity (Textual)                                      
Issuance of common shares                           $ 3,000,000          
Issuance of common shares, shares                           428,571          
Due to related parties                           $ 100,000,000          
Consulting agreement, description                 The Company agreed to indemnify the consultant in an amount of $150 per hour in cash up to $3,000 per month, and issue to Kameyama the Company's Common Stock at $1.00 per share for any amount exceeding $3,000.                    
Collaborative Arrangement One [Member]                                      
Equity (Textual)                                      
Due to related parties                   $ 100,000,000                  
Percentage of payments under collaborative agreement                       6.50%              
Euro-Asia Investment & Finance Corp Ltd. [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Common stock, shares issued                                 50,000    
Common stock, shares issued total                                 80,000    
Consulting Agreement [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Non-employee stock-based compensation                             $ 28,800 $ 5,400      
Common stock, shares issued                                 4,828    
Common stock, shares issued total                                 7,725    
Co-Dev Agreement [Member]                                      
Equity (Textual)                                      
Due to related parties                                     $ 3,000,000
Euro-Asia Agreement [Member]                                      
Equity (Textual)                                      
Non-employee stock-based compensation                             0 60,000      
Kimho Agreement [Member]                                      
Equity (Textual)                                      
Non-employee stock-based compensation                             $ 0 $ 90,000      
BioKey [Member]                                      
Equity (Textual)                                      
Common stock issued post-stock split     1,642,291 104,558,777                              
Issuance of common shares, shares     29,561,231 29,561,231                              
BioLite [Member]                                      
Equity (Textual)                                      
Common stock issued post-stock split       104,558,777                              
Issuance of common shares, shares       74,997,546                              
Officer One [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Common stock, shares issued                                 50,000    
Common stock, shares issued total                                 80,000    
Officer Two [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Common stock, shares issued                                 50,000    
Common stock, shares issued total                                 80,000    
Officer Three [Member]                                      
Equity (Textual)                                      
Common stock, par value                                 $ 1.60    
Common stock, shares issued                                 50,000    
Common stock, shares issued total                                 80,000